Assessing the effects of HIV disease on TB and type 2 diabetes mellitus in a TB patient cohort in Western Cape Province, South Africa01/01/2021 - 12/31/2021 (Key Person / Mentor)
Providence/Boston Center for AIDS Research NIH NIAID
Using care coordination to support vulnerable patients with risk of Tuberculosis Disease RENEWAL07/01/2024 - 06/30/2027 (PI)
Massachusetts Dept. of Public Health / DPH
Using care coordination to support vulnerable patients with risk of Tuberculosis Disease10/01/2023 - 06/30/2027 (PI)
Massachusetts Dept. of Public Health / DPH
An RNA nanosensor for the diagnosis of antibiotic resistance in M. tuberculosis09/13/2023 - 08/31/2025 (Subcontract PI)
PI:
Karen R. Jacobson, MD, MPHHarvard Medical School NIH NIAID1R01AI176498-01
Investigating bacterial contributions to TB treatment response: a focus on in-host pathogen dynamics09/22/2020 - 08/31/2025 (Subcontract PI)
PI:
Karen R. Jacobson, MD, MPHHarvard Medical School NIH NIAID
Administrative Supplement to Transmission Of Tuberculosis Among illicit drug use Linkages (TOTAL)08/01/2023 - 07/31/2025 (PI)
National Institute of Allergy and Infectious Diseases/NIH/DHHS5R01AI147316-05
Transmission Of Tuberculosis Among illicit drug use Linkages (TOTAL)08/01/2019 - 07/31/2025 (PI)
National Institute of Allergy and Infectious Diseases/NIH/DHHS1R01AI147316-01
Core L - The Providence/Boston Center for AIDS Research (CFAR) competitive renewal07/01/2023 - 06/30/2025 (Subcontract PI)
PI:
Karen R. Jacobson, MD, MPHThe Miriam Hospital NIH NIAID
Evaluating the tuberculosis epidemic in South Africa using a novel ten year national cohort04/13/2020 - 03/31/2025 (Multi-PI)
PI:
Karen R. Jacobson, MD, MPHDMMH - A Division of WITS Health Consortium NIH NIAID1R01AI152126-01
MassCPR COVID biorepository work10/01/2021 - 12/31/2024 (Subcontract PI)
PI:
Karen R. Jacobson, MD, MPHHarvard Medical School China Evergrande Gr
An RNA Based Phenotypic Assay for the Diagnosis of Antibiotic Resistance in M. Tuberculosis09/13/2023 - 09/12/2024 (Subcontract PI)
PI:
Karen R. Jacobson, MD, MPHHarvard Medical School NIH NIAID1R01AI176498-01
Showing 10 of 23 results.
Show All Results
Providence Boston Center for AIDS Research (CFAR)07/01/2019 - 06/30/2023 (Multi-PI)
PI:
Karen R. Jacobson, MD, MPHThe Miriam Hospital NIH NIAID5P30AI042853-24
Deep sequencing of pathogens to precisely define transmission networks using rare variants06/01/2021 - 05/31/2023 (Subcontract PI)
PI:
Karen R. Jacobson, MD, MPHHarvard School of Public Health NIH NIAID5R01AI128344-05
The impact of alcohol consumption on TB treatment outcomes04/01/2020 - 03/31/2023 (PI)
National Institute of Allergy and Infectious Diseases/NIH/DHHS5R01AI119037-04
Evidence of the burden of diabetes, gaps in the diabetes cascade-of-care and the impact of care and treatment on diabetes outcomes in HIV-positive and HIV-negative patients in South Africa06/01/2021 - 08/31/2022 (Subcontract PI)
PI:
Karen R. Jacobson, MD, MPHBoston University School of Public Health NIH NIDDK3K01DK116929-03S1
Biomarkers and Mechanisms of Paucibacillary and Latent Tuberculosis11/01/2018 - 07/31/2022 (Subcontract PI)
PI:
Karen R. Jacobson, MD, MPHRutgers The State University of New Jersey NIH NIAID5U19AI111276-08
an Evergrande COVID-19 Response Fund Award from the Massachusetts Consortium on Pathogen Readiness (“MassCPR”)
05/01/2020 - 04/30/2022 (Subcontract PI)
PI:
Karen R. Jacobson, MD, MPHHarvard Medical School China Evergrande Gr
Competitive Revision to Existing NIH Grants NIGMS - Predictive Models for the Spread of Coronaviruses and Related Pathogens04/01/2020 - 03/31/2022 (Subcontract PI)
PI:
Karen R. Jacobson, MD, MPHTrustees of Boston University, BUMC NIH NIGMS
URBAN ARCH (3/5) Uganda Cohort- TB prevention therapy for HIV-infected alcohol drinkers in Uganda…09/22/2016 - 08/31/2021 (Subcontract PI)
PI:
Karen R. Jacobson, MD, MPHUniversity of California, San Francisco NIH NIAAA
MassCPR05/01/2020 - 04/30/2021 (Subcontract PI)
PI:
Karen R. Jacobson, MD, MPHHarvard Medical School MLSC
ASTMH Fellowship in Tropical Infectious Diseases02/01/2013 - 11/30/2018 (PI)
American Society of Tropical Medicine and Hygiene
Phase 2 Pharmacodynamic Study of Hidh-dose Levofloxacin in MDR-TB Treatment01/01/2015 - 07/31/2018 (PI)
Trustees of Boston University NIH-NIAID
Lifespan/Tufts/Brown Center for AIDS Research(CFAR): SWG107/01/2017 - 06/30/2018 (PI)
Miriam Hospital NIH-NIAID
Geospatial clustering and molecular and social epidemiology of drug resistant TB08/01/2013 - 12/31/2016 (PI)
NIH-FIC5K01TW009213-6